European Heart Journal
The European Heart Journal is an international, English language, peer-reviewed journal dealing with cardiovascular medicine. It is an official journal of the European Society of Cardiology and is published weekly. The European Heart Journal aims to publish the highest quality m...
Unclaimed profile — some fields may be incomplete.
Metrics
Campos Scimago / CoP — sin series inventadas
SJR Impact
4,987
H-index
367
Docs (year)
848
Docs 3y
2635
Total refs
23624
Cites 3y
19241
Citable 3y
1544
Cites/Doc 2y
7.46
Ref/Doc
27.86
Immediate OA
3696 €
Embargoed OA
NPD
Non OA / Submission
0 €
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
CagA-positive cytotoxic H. pylori strains as a link between plaque instability and atherosclerotic stroke
View moreWalk test at increased levels of heart rate in patients with dual-chamber pacemaker and with normal or depressed left ventricular function
View moreCompelling evidence for SGLT2 inhibitors and GLP-1 receptor agonists as first-line therapy in patients with diabetes at very high/high cardiovascular risk
View moreComments on the European guidelines on cardiovascular disease prevention
View moreComments on the 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases
View moreClinical outcomes of stents versus balloon angioplasty in non-acute coronary artery disease A meta-analysis of randomized controlled trials
View moreClarifying the importance of CYP2C19 and PON1 in the mechanism of clopidogrel bioactivation and in vivo antiplatelet response
View moreChronic heart failure: pathophysiology and therapeutic approaches - why is the kidney so important?
View moreChlamydial endocarditis: a report on ten cases
View moreChlamydia pneumoniae IgA titres and coronary heart disease. Prospective study and meta-analysis
View moreChlamydia pneumonia (and other infective agents) in atherosclerosis and acute coronary syndromes. How good is the evidence?
View moreChagas cardiomyopathy: Europe is not spared!
View moreCardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol
View more13-year follow-up of the German angioplasty bypass surgery investigation
View moreCabins, castles, and constant hearts: rhythm control therapy in patients with atrial fibrillation
View moreBeta-blockers, psychological influences and erectile dysfunction: Reply
View moreAuthors reply to the letter titled: 'Mortality in congestive heart failure complicated by atrial fibrillation'
View moreAtrial structural remodelling and restoration of atrial contraction after linear ablation for atrial fibrillation
View moreAssociation of lipoproteins with cytokines and cytokine receptors in heart failure patients Differences between ischaemic versus idiopathic cardiomyopathy
View moreArrhythmogenic right ventricular cardiomyopathy: evidence for progression increases
View moreAn international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry
View moreAccuracy of dual-source computed tomography to identify significant coronary artery disease in patients with atrial fibrillation: comparison with coronary angiography
View moreA prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS)
View moreA paradigm shift in treatment for atrial fibrillation: from electrical to structural therapy?
View more